270 related articles for article (PubMed ID: 19730188)
1. Closing the loop around esophagectomy after neoadjuvant therapy.
Demeester SR
Ann Surg; 2009 Sep; 250(3):500; author reply 500. PubMed ID: 19730188
[No Abstract] [Full Text] [Related]
2. Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer.
Schneider PM; Metzger R; Schaefer H; Baumgarten F; Vallbohmer D; Brabender J; Wolfgarten E; Bollschweiler E; Baldus SE; Dienes HP; Hoelscher AH
Ann Surg; 2008 Dec; 248(6):902-8. PubMed ID: 19092334
[TBL] [Abstract][Full Text] [Related]
3. Multi-modality treatment in oesophageal cancer: a curse for radiotherapy progress.
Tait DM
Radiother Oncol; 2004 Nov; 73(2):115-7. PubMed ID: 15542157
[No Abstract] [Full Text] [Related]
4. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
Elsaleh H; Farrell JJ; Crane CH
J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
[No Abstract] [Full Text] [Related]
5. [Downstaging of esophageal carcinoma after preoperative radio- and chemotherapy].
Staar S
Strahlenther Onkol; 1996 Dec; 172(12):693-5. PubMed ID: 8992641
[No Abstract] [Full Text] [Related]
6. [Laparoscopic esophagectomy in palliative treatment of advanced esophageal carcinoma after neoadjuvant radiochemotherapy].
Del Genio A
G Chir; 2005 Apr; 26(4):121-9. PubMed ID: 16035246
[No Abstract] [Full Text] [Related]
7. Effect of chemoradiotherapy for neural invasion in an advanced esophageal cancer.
Tanaka A; Ishikawa S; Okuno K; Shiozaki H
Hepatogastroenterology; 2008; 55(84):963-6. PubMed ID: 18705308
[TBL] [Abstract][Full Text] [Related]
8. [Neoadjuvant chemoradiotherapy in patients with surgically treated T4 esophageal squamous cell carcinnoma].
Shiozaki H; Yano M
Nihon Geka Gakkai Zasshi; 2002 Mar; 103(3):284-9. PubMed ID: 11968758
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma of the esophagus: treat with how many modalities?
Cheng S; Iannettoni M; Koshy M; Suntharalingam M; Urba S
Semin Oncol; 2009 Dec; 36(6):493-7. PubMed ID: 19995639
[No Abstract] [Full Text] [Related]
10. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
Chen G; Wang Z; Liu XY; Liu FY
Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
[TBL] [Abstract][Full Text] [Related]
11. [Treatment and prognosis of primary esophageal small cell carcinoma: a report of 151 cases].
Song Y; Wang LH; He J; Wang JW
Ai Zheng; 2009 Mar; 28(3):303-7. PubMed ID: 19619447
[TBL] [Abstract][Full Text] [Related]
12. [The local control of radiotherapy following Ivor-Lewis esophagectomy in the patients with stage II A middle-third thoracic esophageal cancer].
Zhang MY; Wang Z; Liu XY; Chen G; Liu FY
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(14):1048-50. PubMed ID: 19094527
[TBL] [Abstract][Full Text] [Related]
13. Pre-operative chemo-radiotherapy improves 3-year survival in people with resectable oesophageal cancer.
Naughton P; Walsh TN
Cancer Treat Rev; 2004 Feb; 30(1):141-4. PubMed ID: 14766133
[No Abstract] [Full Text] [Related]
14. Clinical utility of postchemoradiation endoscopic brush cytology and biopsy in predicting residual esophageal adenocarcinoma.
Peng HQ; Halsey K; Sun CC; Manucha V; Nugent S; Rodgers WH; Suntharalingam M; Greenwald BD
Cancer; 2009 Dec; 117(6):463-72. PubMed ID: 19806643
[TBL] [Abstract][Full Text] [Related]
15. [Surgical treatment of esophageal tumors including local ablation].
Hölscher AH; Vallböhmer D
Zentralbl Chir; 2007 Apr; 132(2):W18-36; quiz W37-8. PubMed ID: 17516311
[No Abstract] [Full Text] [Related]
16. Oesophagectomy for tumours and dysplasia of the oesophagus and gastro-oesophageal junction.
Epari K; Cade R
ANZ J Surg; 2009 Apr; 79(4):251-7. PubMed ID: 19432710
[TBL] [Abstract][Full Text] [Related]
17. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of oesophageal cancer.
Veuillez V; Rougier P; Seitz JF
Best Pract Res Clin Gastroenterol; 2007; 21(6):947-63. PubMed ID: 18070697
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: practical guidelines and current issues.
Chang F; Deere H; Mahadeva U; George S
Am J Clin Pathol; 2008 Feb; 129(2):252-62. PubMed ID: 18208806
[TBL] [Abstract][Full Text] [Related]
19. Transhiatal esophagectomy after previous right pneumonectomy.
Velotta JB; Vasquez CR; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2014 Aug; 148(2):e150-2. PubMed ID: 24907004
[No Abstract] [Full Text] [Related]
20. Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer.
Brabender J; Arbab D; Huan X; Vallböhmer D; Grimminger P; Ling F; Neiss S; Bollschweiler E; Schneider PM; Hölscher AH; Metzger R
Ann Surg Oncol; 2009 May; 16(5):1378-83. PubMed ID: 19224282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
